S3 Episode 4: What Clinicians Should Know About Use of Cannabis, Medicinal Mushrooms, and Psyched…
| thcscout | Medical | No Comments on S3 Episode 4: What Clinicians Should Know About Use of Cannabis, Medicinal Mushrooms, and Psyched…
Share
- No bookmark found
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002449. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Mushroom-Derived Bioactive Compounds Pharmacological Properties and Cancer Targeting: A Holistic Assessment https://pubmed.ncbi.nlm.nih.gov/40314874/
Phase 1 Clinical Trial of Trametes versicolor in Women With Breast Cancer https://pubmed.ncbi.nlm.nih.gov/22701186/
Reishi Mushroom for Fatigue and/or Arthralgias for Patients With Breast Cancer on Aromatase Inhibitors https://www.mayo.edu/research/clinical-trials/cls-20555252
Review of Psilocybin Use for Depression Among Cancer Patients After Approval in Oregon https://pubmed.ncbi.nlm.nih.gov/38730654/
Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis https://pubmed.ncbi.nlm.nih.gov/39230883/
Symptom Improvements and Adverse Effects With Reishi Mushroom Use: A Cross-Sectional Survey of Cancer Patients https://pubmed.ncbi.nlm.nih.gov/39635077/
Cannabis Use Among Recently Treated Cancer Patients: Perceptions and Experiences https://pubmed.ncbi.nlm.nih.gov/37650961/
Understanding Feeling “High” and Its Role in Medical Cannabis Patient Outcomes https://pubmed.ncbi.nlm.nih.gov/37292156/
Metabolism and Liver Toxicity of Cannabidiol https://pubmed.ncbi.nlm.nih.gov/38904421/
Interaction Between Warfarin and Cannabis https://pubmed.ncbi.nlm.nih.gov/30326170/
Society of Cannabis Clinicians https://www.cannabisclinicians.org/











